ImmunityBio, Inc. IBRX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s total cost of revenue?
- ImmunityBio, Inc. (IBRX) reported total cost of revenue of $238K in Q1 2026.
- How has ImmunityBio, Inc.'s total cost of revenue changed year-over-year?
- ImmunityBio, Inc.'s total cost of revenue increased by 310.3% year-over-year, from $58K to $238K.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.